ストックスクリーナーアプリを入手
10.87
3.29%
-0.37
前日終値:
$11.24
開ける：
$11.25
24時間の取引高:
571.91K
Relative Volume:
0.58
時価総額：
$945.82M
収益：
-
当期純損益:
$-106.81M
株価収益率:
-3.2823
EPS:
-3.3117
ネットキャッシュフロー:
$-8.40M
1週間 パフォーマンス:
+2.74%
1か月 パフォーマンス:
+25.23%
6か月 パフォーマンス:
+9.25%
1年 パフォーマンス:
-32.19%
1日の値動き範囲:
$10.72
$11.29
1週間の範囲:
$10.47
$11.55
52週間の値動き範囲:
$5.1501
$16.81
Immunome Inc Stock (IMNM) Company Profile
IMNM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
10.87 | 978.02M | 0 | -106.81M | -8.40M | -3.3117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-02 | 開始されました | Lake Street | Buy |
| 2024-11-08 | 開始されました | Stephens | Overweight |
| 2024-05-31 | 開始されました | Piper Sandler | Overweight |
| 2024-04-30 | 開始されました | JP Morgan | Overweight |
| 2024-04-15 | 開始されました | Guggenheim | Buy |
| 2024-01-29 | 開始されました | Leerink Partners | Outperform |
| 2023-12-19 | 開始されました | Wedbush | Outperform |
| 2021-10-29 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Immunome Inc (IMNM) 最新ニュース
What analysts say about Immunome Inc. stockExplosive capital appreciation - PrintWeekIndia
Immunome Inc. Stock Analysis and ForecastFastest return on investment - PrintWeekIndia
Immunome, Inc. (NASDAQ:IMNM) Shares Acquired by Arizona State Retirement System - Defense World
Is Immunome Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com
Teacher Retirement System of Texas Boosts Stock Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
What drives Immunome Inc. stock priceTriple-digit wealth increases - Autocar Professional
Will Immunome Inc. stock benefit from AI tech trendsAnalyst Grade Signals - Newser
What makes Immunome Inc. stock attractive to long term investorsPrecision Entry Strategy - Newser
Immunome Inc (IMNM) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com
Bullish Immunome Insiders Loaded Up On US$3.84m Of Stock - simplywall.st
Unraveling Immunome's 15% Surge: Technical Bullishness or Hidden Catalysts? - AInvest
Immunome's 13% Spike: Unraveling the Mysterious Rally - AInvest
(IMNM) Trading Report - news.stocktradersdaily.com
Unraveling the Immunome Stock Surge: A Technical and Market Behavior Deep Dive - AInvest
How Immunome Inc. stock performs during market volatilityBreakout Momentum Alerts - Newser
What makes Immunome Inc. stock price move sharply2x 3x 5x Pick Alert - Newser
Why Immunome Inc. stock attracts strong analyst attentionFree Investment Community - Newser
Immunome, Inc. (NASDAQ:IMNM) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Wealth Enhancement Advisory Services LLC Boosts Stock Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome (IMNM) Soars 6.0%: Is Further Upside Left in the Stock? - MSN
Immunome's Inducement Grants: A Balancing Act Between Talent Acquisition and Equity Dilution - AInvest
Immunome (IMNM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Trend Tracker for (IMNM) - news.stocktradersdaily.com
Immunome, Inc. (NASDAQ:IMNM) Stake Raised by Wealth Enhancement Advisory Services LLC - Defense World
Wall Street Analysts See a 158.17% Upside in Immunome (IMNM): Can the Stock Really Move This High? - sharewise
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 14,328 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome Inc (IMNM) 財務データ
収益
当期純利益
現金流量
EPS
Immunome Inc (IMNM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Higgins Jack | Chief Scientific Officer |
Mar 27 '25 |
Option Exercise |
1.35 |
5,200 |
7,020 |
18,729 |
| BIENAIME JEAN JACQUES | Director |
Mar 25 '25 |
Buy |
7.78 |
7,800 |
60,684 |
31,415 |
| SIEGALL CLAY B | President and CEO |
Mar 26 '25 |
Buy |
7.29 |
137,100 |
999,459 |
806,736 |
| BIENAIME JEAN JACQUES | Director |
Mar 24 '25 |
Buy |
8.21 |
7,000 |
57,470 |
23,615 |
| Tsai Philip | Chief Technology Officer |
Mar 24 '25 |
Buy |
8.42 |
12,300 |
103,566 |
33,300 |
| SIEGALL CLAY B | President and CEO |
Jan 31 '25 |
Buy |
7.75 |
150,000 |
1,162,500 |
669,636 |
| SIEGALL CLAY B | President and CEO |
Nov 21 '24 |
Buy |
9.54 |
66,057 |
630,263 |
485,693 |
| SIEGALL CLAY B | President and CEO |
Nov 22 '24 |
Buy |
9.78 |
33,943 |
331,918 |
519,636 |
| Lechleider Robert | Chief Medical Officer |
Nov 21 '24 |
Buy |
9.48 |
15,805 |
149,800 |
15,805 |
| Tsai Philip | Chief Technology Officer |
Nov 21 '24 |
Buy |
9.43 |
21,000 |
198,030 |
21,000 |
0.97%
0.22%
大文字化:
|
ボリューム (24 時間):